Business Context and Reporting Period
This Form 8-K Current Report was filed by Envue Medical, Inc. (formerly NanoVibronix, Inc.) on December 8, 2025. The report details a corporate name change and a corresponding change in the company's stock ticker symbol effective December 12, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
- Corporate Name: Changed from "NanoVibronix, Inc." to "Envue Medical, Inc."
- Stock Ticker Symbol: Changed from "NAOV" to "FEED" on the Nasdaq Capital Market.
- Effective Date: Both changes became effective on December 12, 2025.
- Security Rights: The changes do not affect the rights of security holders, and the CUSIP number remains unchanged.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on future outlook, or specific risk factors related to operations. The document notes that stockholder approval was not required for the name change under Section 242 of the Delaware General Corporation Law. Information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the new ticker symbol "FEED" on the Nasdaq Capital Market starting December 12, 2025.
- Confirm that existing holdings under "NAOV" automatically transition to "FEED" without action required by the investor.
- Review the Certificate of Amendment (Exhibit 3.1) for any additional corporate bylaw changes not summarized in the main text.
- Check subsequent filings for the first financial report issued under the new corporate name.